Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs DUOL✓SelectedUSD · DUOLGSK vs DUOL performance historyLatest closeAs of-0.13%11/20
Stock and ETF performance explorer

GSK vs DUOL

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+41.1%
DUOL return
+6.7%
Excess return
+34.4%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioDUOLExcessAlpha
1D-0.1%-2.9%+2.8%-0.1%
7D-5.3%-12.3%+6.9%-5.2%
30D-3.7%+5.6%-9.3%-3.8%
3M-7.3%-1.4%-5.9%-7.3%
6M-4.2%+35.8%-40.0%-4.3%
YTD+0.9%-17.4%+18.2%+1.1%
1Y+7.3%-13.7%+21.0%+7.4%
3Y+52.7%-33.0%+85.7%+52.1%
All+41.1%+6.7%+34.4%+35.0%

Cumulative growth

Daily Returns

Daily percentage return beside DUOL.

Daily Out/Under-Performance

Portfolio return minus DUOL return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × DUOL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded DUOL wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling